A Study in Healthy Men to Test How BI 1810631 is Taken up in the Body When Taken With or Without Food

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The main objective of this trial is to investigate the relative bioavailability of a single dose of BI 1810631 intended commercial formulation (iCF) under fed (Test treatment, T) and fasted (Reference treatment, R) conditions.
Epistemonikos ID: 6ce7d099af614595b72fa35a90c9a4e426102f51
First added on: May 15, 2024